April 2024 FDA Recall Timolol Maleate by Fdc Limited
D-0488-2024 - Defective Container

This Class II drug recall was voluntarily initiated by Fdc Limited on April 25, 2024 for the product Timolol Maleate. The FDA reported the reason for recall as defective container. The product was distributed in New Jersey Only and the recall is currently terminated.

Recall Number: D-0488-2024

Reason for Recall
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
Initiated
04-25-2024
Reported
05-15-2024
Quantity
382,104 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ

Batch or Lot Expiration Information

Lot# : a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.